Akihiro Ono

730 total citations
44 papers, 568 citations indexed

About

Akihiro Ono is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Akihiro Ono has authored 44 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Immunology. Recurrent topics in Akihiro Ono's work include Lung Cancer Treatments and Mutations (7 papers), Asthma and respiratory diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Akihiro Ono is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Asthma and respiratory diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Akihiro Ono collaborates with scholars based in Japan, United States and France. Akihiro Ono's co-authors include Takeshi Hisada, Kunio Dobashi, Tamotsu Ishizuka, Mitsuyoshi Utsugi, Masatomo Mori, Yasuo Shimizu, Yasuhiko Koga, Haruka Aoki, Tadayoshi Kawata and Fumikazu Okajima and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Akihiro Ono

37 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiro Ono Japan 14 148 143 142 141 93 44 568
Tadayoshi Kawata Japan 11 146 1.0× 197 1.4× 99 0.7× 106 0.8× 66 0.7× 21 515
Hiroaki Tsurumaki Japan 13 193 1.3× 71 0.5× 156 1.1× 109 0.8× 127 1.4× 33 515
Naohiro Yamashita Japan 14 218 1.5× 199 1.4× 99 0.7× 77 0.5× 130 1.4× 49 753
Preeti Kanikarla Marie United States 16 260 1.8× 67 0.5× 80 0.6× 191 1.4× 224 2.4× 28 803
Yunfeng Xia China 15 225 1.5× 132 0.9× 64 0.5× 45 0.3× 68 0.7× 37 643
Giovanna Baccante Italy 15 172 1.2× 119 0.8× 50 0.4× 85 0.6× 77 0.8× 19 546
Zhaoya Liu China 13 306 2.1× 104 0.7× 104 0.7× 69 0.5× 44 0.5× 26 656
Cristina Alonso‐Montes Spain 15 302 2.0× 44 0.3× 126 0.9× 78 0.6× 78 0.8× 39 851
Shi‐Juan Chen United States 12 124 0.8× 130 0.9× 168 1.2× 167 1.2× 50 0.5× 13 844
Satoshi Aiko Japan 16 232 1.6× 66 0.5× 232 1.6× 145 1.0× 150 1.6× 42 840

Countries citing papers authored by Akihiro Ono

Since Specialization
Citations

This map shows the geographic impact of Akihiro Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Ono more than expected).

Fields of papers citing papers by Akihiro Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Ono. The network helps show where Akihiro Ono may publish in the future.

Co-authorship network of co-authors of Akihiro Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Ono. A scholar is included among the top collaborators of Akihiro Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Ono. Akihiro Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ono, Akihiro, Masaki Nakamura, Masashi Kusakabe, et al.. (2024). Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditary leiomyomatosis and renal cell cancer syndrome. IJU Case Reports. 7(2). 144–147.
2.
Imai, Hisao, Yoshiaki Nagai, Akihiro Ono, et al.. (2024). Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer. Internal Medicine. 64(1). 55–64. 2 indexed citations
3.
Nakamura, Masaki, Shuji Kameyama, Akihiro Ono, et al.. (2024). Predictors of renal function deterioration at one year after off-clamp non-renorrhaphy partial nephrectomy. PLoS ONE. 19(5). e0303104–e0303104.
4.
Nakamura, Masaki, Akihiro Ono, Yoshio Masuda, et al.. (2023). Asymptomatic renal granuloma diagnosed 3 years after Bacillus Calmette–Guérin intravesical injection: A case report and a literature review. IJU Case Reports. 6(6). 377–381. 1 indexed citations
5.
6.
7.
Kaira, Kyoichi, Noriko Yanagitani, Noriaki Sunaga, et al.. (2017). Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer. Oncology Letters. 14(1). 1123–1128. 4 indexed citations
8.
Koga, Yasuhiko, Takeshi Hisada, Tamotsu Ishizuka, et al.. (2016). CREB regulates TNF-α-induced GM-CSF secretion via p38 MAPK in human lung fibroblasts. Allergology International. 65(4). 406–413. 25 indexed citations
9.
Kaira, Kyoichi, Noriaki Sunaga, Hisao Imai, et al.. (2015). Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer. International Journal of Clinical Oncology. 21(2). 240–247. 3 indexed citations
10.
Kaira, Kyoichi, Yoshio Tomizawa, Akihiro Yoshii, et al.. (2013). Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer. Lung Cancer. 82(1). 103–108. 7 indexed citations
11.
Matsuzaki, Shinichi, Tamotsu Ishizuka, Takeshi Hisada, et al.. (2010). Lysophosphatidic Acid Inhibits CC Chemokine Ligand 5/RANTES Production by Blocking IRF-1–Mediated Gene Transcription in Human Bronchial Epithelial Cells. The Journal of Immunology. 185(8). 4863–4872. 26 indexed citations
12.
Utsugi, Mitsuyoshi, Kunio Dobashi, Akihiro Ono, et al.. (2010). JNK1 and JNK2 differently regulate IL-12 production in THP-1 macrophage cells. Cytokine. 51(2). 127–131. 7 indexed citations
13.
Utsugi, Mitsuyoshi, Kunio Dobashi, Akihiro Ono, et al.. (2009). PI3K p110β Positively Regulates Lipopolysaccharide-Induced IL-12 Production in Human Macrophages and Dendritic Cells and JNK1 Plays a Novel Role. The Journal of Immunology. 182(9). 5225–5231. 42 indexed citations
14.
Koike, Yoko, Takeshi Hisada, Mitsuyoshi Utsugi, et al.. (2007). Glutathione Redox Regulates Airway Hyperresponsiveness and Airway Inflammation in Mice. American Journal of Respiratory Cell and Molecular Biology. 37(3). 322–329. 72 indexed citations
15.
Utsugi, Mitsuyoshi, Kunio Dobashi, Tamotsu Ishizuka, et al.. (2006). Rac1 Negatively Regulates Lipopolysaccharide-Induced IL-23 p19 Expression in Human Macrophages and Dendritic Cells and NF-κB p65 trans Activation Plays a Novel Role. The Journal of Immunology. 177(7). 4550–4557. 31 indexed citations
16.
Shimizu, Yasuo, Akihiro Ono, Seiichi Higuchi, et al.. (2006). Intracellular Th1/Th2 Balance of Pulmonary CD4+T Cells in Patients with Active Interstitial Pneumonia Evaluated by Serum KL-6. Immunopharmacology and Immunotoxicology. 28(2). 295–304. 21 indexed citations
17.
Dobashi, Kunio, et al.. (2003). Levofloxacin 300 mg Once-daily Versus Levofloxacin 100 mg Three-times-daily in the Treatment of Respiratory Tract Infections in Elderly Patients. The Kitakanto Medical Journal. 53(3). 251–255. 4 indexed citations
18.
Abe, Takashi, Akira Yachi, Tomofumi Igarashi, et al.. (1992). Thoracic Extramedullary Hematopoiesis Associated with Hereditary Spherocytosis.. Internal Medicine. 31(9). 1151–1154. 12 indexed citations
19.
Ishida, Tadao, et al.. (1989). A case of adult T-cell leukemia (ATL) developed acute hepatic failure as the initial manifestation.. Kanzo. 30(9). 1026–1031. 1 indexed citations
20.
Tsujisaki, Masayuki, et al.. (1988). Idiotype analysis and immune response with use of anti-idiotypic monoclonal antibody to anti-CEA antibody.. Drug Delivery System. 3(3). 399–404. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadayoshi Kawata Breakdown of academic impact, for papers by Hiroaki Tsurumaki Breakdown of academic impact, for papers by Naohiro Yamashita Breakdown of academic impact, for papers by Preeti Kanikarla Marie Breakdown of academic impact, for papers by Yunfeng Xia Breakdown of academic impact, for papers by Giovanna Baccante Breakdown of academic impact, for papers by Zhaoya Liu Breakdown of academic impact, for papers by Cristina Alonso‐Montes Breakdown of academic impact, for papers by Shi‐Juan Chen Breakdown of academic impact, for papers by Satoshi Aiko
Rankless by CCL
2026